Injective (INJ) is currently trading at $3.26, having experienced a slight decline of 1.42% over the past 24 hours. The price has fluctuated between a 24-hour high of $3.38 and a low of $3.25, indicating a daily range of only 0.13%, which suggests limited volatility in the short term.

Trading volume stands at approximately 43.94 million, contributing to a volume-to-market cap ratio of 13.50%. The moving averages reveal a bearish trend, with the 8, 13, and 21 SMAs all indicating negative changes of around 2.26% to 2.29%, while the 55 and 144 SMAs show a less pronounced decline of around 1.36% to 1.28%.

The one-hour Relative Strength Index (RSI) is at 35, indicating potential oversold conditions, while the seven-day RSI sits at 47, reflecting a neutral stance over the past week. Price changes over the last 7, 14, and 30 days show a mixed picture, with a minor decline of approximately 0.37% over the week, a 12.48% increase over the past 14 days, and a 6.27% rise over the last month.

Injective's all-time high of $52.62 was reached on March 14, 2024, suggesting significant long-term volatility and potential for recovery from current levels. Given the recent price action, technical indicators, and volume metrics, the market sentiment appears cautious, warranting a careful assessment before making new positions.

Based on the current analysis, a Hold rating is recommended for Injective (INJ). While short-term indicators suggest weakness, the longer-term trends show resilience, and the current price is significantly below its all-time high, presenting potential for future gains. However, traders should monitor for confirmation of upward momentum before considering a Buy.